Report for Q3 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(603566)"Pulike Biological Engineering, Inc."Report for Q3 2026
Filed with SSE · Stock code 603566 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)Pulike Biological Engineering, Inc. on 6ix
Earlier from Pulike Biological Engineering
- (603566)"Pulike Biological Engineering, Inc."Announcement on Obtaining the Approval for the Clinical Trial of Veterinary Biological Products
- Announcement on Change of Sponsor Representative for Continuous Supervision and Guidance
- Announcement on Obtaining New Veterinary Drug Registration Certificate by Subsidiary
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Redemption upon Maturity of Cash Management Products Purchased with Idle Raised Funds
Follow Pulike Biological Engineering into a list and get an email when it puts out news.
Follow Pulike Biological Engineering